Boccia Stefania, Miele Luca, Panic Nikola, Turati Federica, Arzani Dario, Cefalo Consuelo, Amore Rosarita, Bulajic Milutin, Pompili Maurizio, Rapaccini Gianlodovico, Gasbarrini Antonio, La Vecchia Carlo, Grieco Antonio
Institute of Public Health, Section of Hygiene, Department of Public Health, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy ; IRCCS San Raffaele Pisana, Via della Pisana 235, 00163 Rome, Italy.
Institute of Internal Medicine, Gemelli Hospital, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy ; Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Via Giuseppe Moscati 31-33, 00168 Rome, Italy.
Biomed Res Int. 2015;2015:179867. doi: 10.1155/2015/179867. Epub 2015 Jan 14.
Aim. The aim of our study was to assess whether selected single nucleotide polymorphisms of CYP1A1 and 2E1, GSTM1, GSTT1, and SULT1A1 influence susceptibility towards HCC, considering their interaction with cigarette smoking. Methods. We recruited HCC cases and controls among patients admitted to the hospital "Agostino Gemelli," from January 2005 until July 2010. Odds ratios (OR) of HCC were derived from unconditional multiple logistic regression. Gene-gene and gene-smoking interaction were quantified by computing the attributable proportion (AP) due to biological interaction. Results. The presence of any CYP2E1 () 5B variant allele (OR: 0.23; 95% CI: 0.06-0.71) and CYP2E1 () 6 variant allele (OR: 0.08; 95% CI: 0.01-0.33) was inversely related to HCC. There was a borderline increased risk among carriers of combined CYP1A1 () 2A and SULT1A1 variant alleles (OR: 1.67; 95% CI: 0.97-3.24). A significant biological interaction was observed between GSTT1 and smoking (AP = 0.48; 95% CI: 0.001-0.815), with an OR of 3.13 (95% CI: 1.69-5.82), and borderline significant interaction was observed for SULT1A1 and smoking (AP = 0.36; 95% CI: -0.021-0.747), with an OR of 3.05 (95% CI: 1.73-5.40). Conclusion. CYP2E1 () 5B and CYP2E1 (*) 6 polymorphisms have a favourable effect on the development of HCC, while polymorphisms of GSTT1 and SULT1A1 might play role in increasing the susceptibility among smokers.
目的。我们研究的目的是评估细胞色素P450 1A1(CYP1A1)和2E1、谷胱甘肽S -转移酶M1(GSTM1)、谷胱甘肽S -转移酶T1(GSTT1)以及磺基转移酶1A1(SULT1A1)的特定单核苷酸多态性是否会影响肝癌易感性,并考虑它们与吸烟的相互作用。方法。我们在2005年1月至2010年7月期间入住“阿戈斯蒂诺·杰梅利”医院的患者中招募了肝癌病例和对照。肝癌的比值比(OR)来自无条件多因素逻辑回归。通过计算生物学相互作用的归因比例(AP)来量化基因 - 基因和基因 - 吸烟相互作用。结果。任何CYP2E1()5B变异等位基因(OR:0.23;95%可信区间:0.06 - 0.71)和CYP2E1()6变异等位基因(OR:0.08;95%可信区间:0.01 - 0.33)的存在与肝癌呈负相关。携带CYP1A1()2A和SULT1A1变异等位基因组合的个体风险有临界性增加(OR:1.67;95%可信区间:0.97 - 3.24)。观察到GSTT1与吸烟之间存在显著的生物学相互作用(AP = 0.48;95%可信区间:0.001 - 0.815),OR为3.13(95%可信区间:1.69 - 5.82),并且观察到SULT1A1与吸烟之间存在临界显著相互作用(AP = 0.36;95%可信区间: - 0.021 - 0.747),OR为3.05(95%可信区间:1.73 - 5.40)。结论。CYP2E1()5B和CYP2E1(*)6多态性对肝癌的发生有有利影响,而GSTT1和SULT1A1多态性可能在增加吸烟者的易感性方面起作用。